hrs4r
 I want to donate

The research group for descriptive epidemiology, genetics, and prevention of cancer is a multidisciplinary group that includes epidemiologists, statisticians, oncologists, radiotherapists, a physiotherapist, a dermatologist; a biologist, a nurse, and medical documentalists, biologist. The main focus of the group is cancer epidemiology (descriptive and analytical), cancer prevention, and genetics.

Main lines of research

Descriptive and analytical epidemiology of cancer.

Strategic objectives
  1. Descriptive and analytical epidemiology of cancer
  • Registering cancer based on population for the province of Girona (with national and international collaborations).
    • Incidence and populational prevalence of cancer, projections of the incidence of cancer
    • Populational survival of cancer (international collaborations: EUROCARE and CONCORD studies).
  • Study of genetic and molecular factors in the prognosis of breast cancer and haematological tumours.
  • Study of genetic and environmental risk factors in breast cancer and chronic lymphocytic leukaemia.
  1. Cancer prevention
  • Evaluation of the organized breast cancer screening program
  • Benefits and adverse effects of breast cancer detection: Method to improve the measurement of early detection results.
  • Evaluation of the interval rate of cancer and its determining factors in the early detection program of breast cancer in the Girona health region.
  • Evaluation of the timely detection program for cervical cancer.
  • Determination of the sensitivity and specificity of cervical cytology.
  • Evaluation of the effectiveness of vaccination against the human papilloma virus.
  1. Genetics (The genetic epidemiology of cancer)
  • Evaluation of the risk of developing cancer.
  • Study of genetic risk factors for cancer.
  • Genetic susceptibility to cancer.
Publications
Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention Descriptive epidemiology, genetics and cancer prevention
0

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)

Neuro-Oncology, 2023, 25, 580-592 dx.doi.org/10.1093/neuonc/noac217

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405

Hernández-Rubio A, Sanvisens A, Barbier-Torres L, Blanes R, Miquel L, Torrens M, Rubio G, Bolao F, Zuluaga P, Fuster D, Rodríguez de Fonseca F, Farré M, Muga R

Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder.

DRUG ALCOHOL DEPEN, 2023, 245, 109822-109822 dx.doi.org/10.1016/j.drugalcdep.2023.109822

Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, Arndt V, Francisci S, Dochez C, Ribes J, Fernández LP, Gavin A, Gatta G, Marcos-Gragera R, Lievens Y, Allemani C, De Angelis R, Visser O, Van Eycken L

Cancer treatment data available in European cancer registries: Where are we and where are we going?

Frontiers in oncology, 2023, 13, 1109978-1109978 dx.doi.org/10.3389/fonc.2023.1109978

Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X

Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening

EUROPEAN RADIOLOGY, 2022, 32, 621-629 dx.doi.org/10.1007/s00330-021-08118-y

OnCovid Study Group, Pinato DJ, Patel M, Scotti L, Colomba E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Dalla Pria A, Aguilar-Company J, Bower M, Salazar R, Bertuzzi A, Brunet J, Lambertini M, Tagliamento M, Pous A, Sita-Lumsden A, Srikandarajah K, Colomba J, Pommeret F, Seguí E, Generali D, Grisanti S, Pedrazzoli P, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Harbeck N, Vincenzi B, Biello F, Bertulli R, Ottaviani D, Liñan R, Rossi S, Carmona-García MC, Tondini C, Fox L, Baggi A, Fotia V, Parisi A, Porzio G, Queirolo P, Cruz CA, Saoudi-Gonzalez N, Felip E, Roqué Lloveras A, Newsom-Davis T, Sharkey R, Roldán E, Reyes R, Zoratto F, Earnshaw I, Ferrante D, Marco-Hernández J, Ruiz-Camps I, Gaidano G, Patriarca A, Bruna R, Sureda A, Martinez-Vila C, Sanchez de Torre A, Berardi R, Giusti R, Mazzoni F, Guida A, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Tabernero J, Van Hemelrijck M, Diamantis N, Gennari A, Cortellini A

Time-Dependent COVID-19 Mortality in Patients With Cancer An Updated Analysis of the OnCovid Registry

JAMA Oncology, 2022, 8, 114-122 dx.doi.org/10.1001/jamaoncol.2021.6199

Sanvisens A, Ameijide A, Carulla M, Marcos-Gragera R

Estimates of the incidence of hematological neoplasms in Spain, 2021: Study of the Spanish Network of Cancer Registries (REDECAN)

MEDICINA CLINICA, 2022, 158, 284-290 dx.doi.org/10.1016/j.medcli.2021.09.035

Solans M, Sanvisens A, Ameijide A, Merino S, Rojas D, Alemán A, Banqueri E, Chico M, Marcos AI, de Castro V, Gil L, de Munain AL, Puigdemont M, Sánchez MJ, Perucha J, Ruiz-Armengol P, Chirlaque MD, Guevara M, Carulla M, Marcos-Gragera R

Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries

SCIENTIFIC REPORTS, 2022, 12, 323-323 dx.doi.org/10.1038/s41598-021-03734-6

Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

Pharmaceuticals, 2022, 15 dx.doi.org/10.3390/ph15010019

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780
Competitive projects
Codi oficial: Projecte IJC - Dr. Rafael Marcos-Gragera Start date:01/01/2021 Data fi: 31/12/2024 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: FUNDACIÓ INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS Ajuda: 12,500 €
Transfer
Guies clíniques

- Adherence to the 2018 WCRF/AICR cancer prevention guidelines and chronic lymphocytic leukemia in the MCC-Spain study.

- A Poveda; V Martinez; C Serrano; I Sevilla; M J Lecumberri; RD de Beveridge; A Estival; D Vicente; J Rubió; J Martin-Broto J. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clinical Translational Oncology. Dec;18(12):1221-1228

- Gavin A,Rous B, Marcos-Gragera R, Middleton R, Steliarova-Foucher E, Maynadie M, Zanetti R, Visser O; European Network of Cancer Registries. “Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses”. European Journal of Cancer. 2015 Jun;51(9):1109-22. doi: 10.1016/j.ejca.2014.02.008

- Luque R,Benavides M,Del Barco S,Egaña L,García J,Martínez M,Pérez P,Pineda E,Sepúlveda JM,Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021. 23(5):p. 940-947. IF:3,405. (Q3).

Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

menu